Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children
REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators
Research output: Contribution to journal › Article › peer-review
18Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children'. Together they form a unique fingerprint.